September 25, 2022
Vaccine Delivery Devices Market Size Forecast 2022-2027 | Industry Analysis, Report, Share, Growth, Trends

 The global vaccine delivery devices market size reached US$ 6.44 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 10.23 Billion by 2027 exhibiting a growth rate (CAGR) of 7.80% during 2022-2027.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

A vaccine refers to a biological substance used for protecting individuals from bacterial diseases by stimulating the immune response of the body against them. It assists in producing antibodies against the invading antigens when given at specific intervals. A vaccine can be delivered to the body via microspheres, liposomes, micellar systems, immune stimulating complexes (ISCOMs), dendrimers, plant-derived viruses, etc. As such, vaccine delivery devices are extensively utilized in hospitals and clinics.

Request free sample brochure: https://www.imarcgroup.com/vaccine-delivery-devices-market/requestsample

Vaccine Delivery Devices Market Trends and Drivers: 

The expanding healthcare sector, owing to the easy access to medical products and services, is primarily driving the vaccine delivery devices market. Additionally, the widespread adoption of needle-free delivery systems as they decrease needle stick injuries as well as vaccine antigen dose and enhance the vaccine immunogenicity is further catalyzing the market growth.

Apart from this, the leading manufacturers are also focusing on using novel delivery technologies that increase the therapeutic value of vaccines by reducing toxicity, which is acting as another significant growth-inducing factor. Moreover, numerous advancements in the systematic delivery of vaccines, such as the introduction of micro-needles and electroporation, and the launch of immunization programs by government bodies to prevent disabilities and deaths from vaccine-preventable diseases, are positively influencing the global market.

Besides this, the growing prevalence of chronic disorders and the sudden outbreak of the COVID-19 pandemic are anticipated to fuel the vaccine delivery devices market over the forecasted period.

Vaccine Delivery Devices Market Report Scope

Report Coverage Details
Market size value in 2021 US$ 6.44 Billion
Market forecast in 2027 US$ 10.23 Billion
Growth Rate CAGR of 7.80% from 2022 to 2027
Base year for estimation 2021
Historical data 2016-2021
Forecast period 2022-2027
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Device, Route of Administration and End User
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Key companies profiled 3M Company, Becton Dickinson and Company, Enesi Pharma Limited, Gerresheimer AG, INOVIO Pharmaceuticals, NanoPass, Panacea Biotec Pharma Limited (Panacea Biotec), Pharmajet Inc., Schott AG (Carl-Zeiss-Stiftung), Terumo Corporation and Vaxxas.
Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization preview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Device:

  • Syringes
  • Jet Injectors
  • Others

Breakup by Route of Administration:

  • Intramuscular Vaccination
  • Intradermal Vaccination
  • Subcutaneous Vaccination
  • Others

Breakup by End User:

By Geography:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

List of Major Key Players:

The major players in the market are

  • 3M Company
  • Becton Dickinson and Company
  • Enesi Pharma Limited
  • Gerresheimer AG
  • INOVIO Pharmaceuticals
  • NanoPass
  • Panacea Biotec Pharma Limited (Panacea Biotec)
  • Pharmajet Inc.
  • Schott AG (Carl-Zeiss-Stiftung)
  • Terumo Corporation
  • Vaxxas.

Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/vaccine-delivery-devices-market

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Other Related Report: 

Anesthesia and Respiratory Devices Market 2022-2027: https://www.imarcgroup.com/anesthesia-respiratory-devices-market

Home Medical Equipment Market Share: https://www.imarcgroup.com/home-medical-equipment-market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Source link

Leave a Reply

Your email address will not be published.